If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 64   2003   NUMBER 5

CME Pretest 497

CME Posttest 619

Brainstorms

498 The Ups and Downs of Novel Antiemetic Drugs, Part 1: Substance P, 5-HT, and the Neuropharmacology of Vomiting. Stephen M. Stahl
[PDF]

Original Articles

500 A Review of the Safety and Efficacy of Droperidol for the Rapid Sedation of Severely Agitated and Violent Patients. John H. Shale, Christopher M. Shale, and William D. Mastin
[Abstract] [PDF]

506 Factors Associated With Suicide Attempts in 648 Patients With Bipolar Disorder in the Stanley Foundation Bipolar Network. [CME] Gabriele S. Leverich, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Paul E. Keck, Jr., Susan L. McElroy, Kirk D. Denicoff, Gabriela Obrocea, Willem A. Nolen, Ralph Kupka, Jorg Walden, Heinz Grunze, Sara Perez, David A. Luckenbaugh, and Robert M. Post
[Abstract] [PDF]

516 Residual Symptoms in Depression: Can Treatment Be Symptom-Specific? [CME] Matthew Menza, Humberto Marin, and Rachel Sokol Opper
[Abstract] [PDF]

524 The Effectiveness of Quetiapine Versus Conventional Antipsychotics in Improving Cognitive and Functional Outcomes in Standard Treatment Settings. Dawn I. Velligan, Thomas J. Prihoda, Dawen Sui, Janice L. Ritch, Natalie Maples, and Alexander L. Miller
[Abstract] [PDF]

532 Safety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain. Charles B. Nemeroff
[Abstract] [PDF]

540 Prevalence of Hepatitis A, Hepatitis B, and HIV Among Hepatitis C-Seropositive State Hospital Patients: Results From Oregon State Hospital. Jonathan M. Meyer
[Abstract] [PDF]

546 Venlafaxine in Treatment-Resistant Obsessive-Compulsive Disorder. Eric Hollander, Jennifer Friedberg, Stacey Wasserman, Andrea Allen, Melissa Birnbaum, and Lorrin M. Koran
[Abstract] [PDF]

551 Pretreatment With Ibuprofen to Prevent Electroconvulsive Therapy-Induced Headache. Marianna Leung, Yitzchak Hollander, and Glen R. Brown
[Abstract] [PDF]

554 Chronic Depression and Comorbid Personality Disorders: Response to Sertraline Versus Imipramine. James M. Russell, Susan G. Kornstein, M. Tracie Shea, James P. McCullough, Wilma M. Harrison, Robert M. A. Hirschfeld, and Martin B. Keller
[Abstract] [PDF]

562 Citalopram Treatment of Fluoxetine-Intolerant Depressed Patients. Joseph R. Calabrese, Peter D. Londborg, Melvin D. Shelton, and Michael E. Thase
[Abstract] [PDF]

568 Conventional Antipsychotic Prescription in Unipolar Depression, I: An Audit and Recommendations for Practice. Jason A. Wheeler Vega, Ann M. Mortimer, and Philip J. Tyson
[Abstract] [PDF]

575 Metabolic Syndrome in Patients With Schizophrenia. Tuula Heiskanen, Leo Niskanen, Ruitta Lyytikainen, Pirjo I. Saarinen, and Jukka Hintikka
[Abstract] [PDF]

580 Effectiveness of Switching to Ziprasidone for Stable but Symptomatic Outpatients With Schizophrenia. Peter J. Weiden, George M. Simpson, Steven G. Potkin, and Richard L. O'Sullivan
[Abstract] [PDF]

589 Risperidone Compared With Olanzapine in a Naturalistic Clinical Study: A Cost Analysis. David M. Taylor, Tim Wright, and Susan E. Libretto, for the Risperidone Olanzapine Drug Outcomes Studies in Schizophrenia (RODOS) U.K. Investigator Group
[Abstract] [PDF]

598 Serum Leptin and Triglyceride Levels in Patients on Treatment With Atypical Antipsychotics. Murad Atmaca, Murat Kuloglu, Ertan Tezcan, and Bilal Ustundag
[Abstract] [PDF]

605 Undiagnosed Hyperglycemia in Clozapine-Treated Patients With Schizophrenia. Michael J. Sernyak, Barbara Gulanski, Douglas L. Leslie, and Robert Rosenheck
[Abstract] [PDF]

Letters To the Editor

609 Clozapine and Venous Thromboembolism: Further Evidence. Jean-Paul Selten and Harry Buller
[PDF]

609 Linezolid, a Monoamine Oxidase Inhibiting Antibiotic, and Antidepressants. Vimal M. Aga, Nancy E. Barklage, and James W. Jefferson
[PDF]

611 Olanzapine-Sertraline Combination in Schizophrenia With Obsessive-Compulsive Disorder. Michael Poyurovsky, Rena Kurs, and Abraham Weizman
[PDF]

612 Two Cases of Alcohol Craving Curbed by Topiramate. Ramu Komanduri
[PDF]

612 Quetiapine and QTc Issues: A Case Report. Sanjay Gupta, Kristin Nienhaus, and Syed A. Shah
[PDF]

613 The Efficacy and Safety of Bilateral rTMS in Medication-Resistant Depression. Carl I. Cohen, Vahe E. Amassian, Bola Akande, and Paul J. Maccabee
[PDF]

614 Racial Differences in Use of Antipsychotics Among Patients With Bipolar Disorder. Bonnie L. Szarek and John W. Goethe
[PDF]

  • Reply by David E. Fleck and Stephen M. Strakowski

Book Reviews 616

NOW @ Psychiatrist.com 621

Information for authors

see July 2002, pages 591-593 or our Web siteat www.psychiatrist.com/author.htm